logo

For the Inventor, By the Inventor

South San Francisco, CA, United States of America

Alios Biopharma, Inc.


USPTO Granted Patents = 44



Forward Citations = 975

Loading Chart...
Loading Chart...

54 inventors (with patents filed for the assignee):

goldMedal Leonid Beigelman (39 out of 224 patents)

silverMedal David Bernard Smith (26 out of 88 patents)

bronzeMedal Guangyi Wang (22 out of 55 patents)

4.  Jerome Deval (13 out of 28 patents)

5.  Lawrence M Blatt (7 out of 24 patents)

6.  Natalia Dyatkina (7 out of 23 patents)

7.  Vivek Kumar Rajwanshi (6 out of 18 patents)

8.  Robert Than Hendricks (5 out of 18 patents)

9.  Marija Prhavc (5 out of 19 patents)

10.  Julian Alexander Symons (5 out of 7 patents)

11.  Antitsa Dimitrova Stoycheva (4 out of 19 patents)

12.  Vladimir Serebryany (4 out of 16 patents)

13.  Jyanwei Liu (4 out of 19 patents)

14.  Young Chun Jung (4 out of 13 patents)

15.  William Aloysius Nugent (2 out of 10 patents)


Core Competencies:
Substituted Nucleosides
Nucleotide Analogs
Pyridazinone Compounds
Aza-Pyridone Compounds
Antiviral Compounds
Thiophosphoramidate Prodrug
Cyclic Nucleotide Analogs
Azido Nucleosides
Paramoxyvirus Treatment
Hepatitis C Treatment
Norovirus Infection

44 patents:

1. 10519185 - Methods of preparing substituted nucleoside analogs (2019-12-31),
2. 10485815 - Substituted nucleosides, nucleotides and analogs thereof (2019-11-26),
3. 10464965 - Substituted nucleosides, nucleotides and analogs thereof (2019-11-05),
4. 10364226 - Pyridazinone compounds and uses thereof (2019-07-30),
5. 10358453 - Antiviral compounds (2019-07-23),
6. 10307439 - Substituted nucleosides, nucleotides and analogs thereof (2019-06-04),
7. 10251882 - Aza-pyridone compounds and uses thereof (2019-04-09),
8. 10208045 - Aza-pyridone compounds and uses thereof (2019-02-19),
9. 10183945 - Method of preparing AZA-pyridone compounds (2019-01-22),
10. 10144755 - Substituted nucleosides, nucleotides and analogs thereof (2018-12-04),
11. 10112966 - Substituted nucleosides, nucleotides and analogs thereof (2018-10-30),
12. 10052342 - Substituted nucleosides, nucleotides and analogs thereof (2018-08-21),
13. 9932363 - Substituted nucleosides, nucleotides and analogs thereof (2018-04-03),
14. 9908914 - Methods of preparing substituted nucleoside analogs (2018-03-06),
15. 9890188 - Substituted nucleosides, nucleotides and analogs thereof (2018-02-13),
ALIOS BIOPHARMA, INC. is a pharmaceutical company specializing in the development of innovative antiviral therapies. With a focus on viral diseases, ALIOS BIOPHARMA leverages cutting-edge research and advanced technology to bring breakthrough treatments to patients worldwide. Our diversified portfolio includes novel drug candidates for respiratory viruses, hepatitis, and human immunodeficiency virus (HIV) infections.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

44 Patents

#36 in South San Francisco, CA

#1,813 in California

#7,673 in US

#15,285 in the World

...
South San Francisco, CA, United States of America

Alios Biopharma, Inc.

Forward Citations = 975

54 inventors:

goldMedal Leonid Beigelman (39 out of 224 patents)

silverMedal David Bernard Smith (26 out of 88 patents)

bronzeMedal Guangyi Wang (22 out of 55 patents)

4.  Jerome Deval (13 out of 28 patents)

5.  Lawrence M Blatt (7 out of 24 patents)

Please report any incorrect information to support@idiyas.com
Loading…